Charlotte's Web Holdings, Inc. (CWEB) Earnings Call Transcripts

24 earnings calls from March 2020 to March 31, 2026

TSX CA Health Care Pharmaceuticals

Charlotte's Web Holdings, Inc.'s Latest Earnings Call - Q4 FY2025

In Q4 2025, Charlotte's Web Holdings, Inc. (CWEB:CA) reported consolidated net revenue of $13.3 million, reflecting a 15.8% sequential rebound and a 4.7% year-over-year increase. The company announced a transformative financial transaction with British American Tobacco (BAT), converting $55 million in debt to equity, which eliminates significant liabilities and provides $10 million in fresh capital. Management signaled optimism for future growth, particularly through participation in the Medicare pilot program, which could expand CBD access to millions of beneficiaries, although initial revenue expectations remain cautious.

Reported metrics

MetricValueContext
Q4 Revenue $13.3 million (beat) vs $12.7 million in Q4 2024, +4.7% YoY
Gross Margin 37.5% (miss) impacted by a $1.3 million inventory charge
Net Loss (Q4) $11.4 million (negative) vs a net loss of $3.4 million in Q4 2024
Full Year Revenue $49.9 million (beat) increased 0.5% YoY, first annual revenue increase since 2021
Full Year SG&A Expenses $42 million (beat) down 21.2% from $53.3 million in 2024
Operating Loss (Full Year) $20.3 million (positive) improved from $32 million in 2024

Guidance from management

Management expects gross margins to normalize towards the historical 50% range and anticipates quarterly SG&A for the core business to remain around $10 million to $11 million, excluding launch costs for the Medicare program.

What management said

It's -- I haven't been successful thus far, Pablo speculating where these things are going to land. I want to give this a little bit of time to see how it plays out. We're really head down focused on this transaction was just completed and how we ramp up our readiness for the CMMI program. There's just so much noise in the system right now between federal regulatory, state regulatory, CMMI versus the other things tha...
— William Morachnick, Q4 FY2025 earnings call
Yes. At the end of the day, it's too soon to know exactly where these meetings are going to go in the next few days. We are encouraged that they're occurring but too soon to speculate on exactly where that's going to go. But at the end of the day, we are seeing a convergence of policy. So that's encouraging. Okay. Well, then with that, we seem to have technical difficulties on our end, but that was your final questio...
— Cory Pala, Q4 FY2025 earnings call

What analysts pressed on

Analysts expressed concerns about the potential impact of the upcoming hemp ban in November 2026 on the Medicare pilot program and the overall CBD market. There were also questions regarding the scalability of revenue from the CMMI pilot in the near term.

Main topics on the call

Read the full Charlotte's Web Holdings, Inc. transcript (Q4 FY2025) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Charlotte's Web Holdings, Inc.

Charlotte's Web Holdings, Inc. (CWEB) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on TSX and is based in CA. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 24 calls on record spanning March 24, 2020 to March 31, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 24 Charlotte's Web Holdings, Inc. earnings call transcripts on record, spanning March 24, 2020 to March 31, 2026. Based on this history, Charlotte's Web Holdings, Inc. reports quarterly. The most recent call on file is dated March 31, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
CWEB
Exchange
TSX
Country
CA
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
24
First call
March 24, 2020
Most recent
March 31, 2026
Reporting cadence
quarterly
Quarter Date
Q4 FY2025 Mar 31, 2026 Read transcript
Q2 FY2025 Aug 13, 2025 Read transcript
Q4 FY2024 Mar 19, 2025 Read transcript
Q2 FY2024 Aug 8, 2024 Read transcript
Q1 FY2024 May 8, 2024 Read transcript
Q4 FY2023 Mar 21, 2024 Read transcript
Q3 FY2023 Nov 9, 2023 Read transcript
Q2 FY2023 Aug 10, 2023 Read transcript
Q1 FY2023 May 12, 2023 Read transcript
Q4 FY2022 Mar 23, 2023 Read transcript
Q3 FY2022 Nov 15, 2022 Read transcript
Q2 FY2022 Aug 9, 2022 Read transcript
Q1 FY2022 May 17, 2022 Read transcript
Q4 FY2021 Mar 24, 2022 Read transcript
Q3 FY2021 Nov 15, 2021 Read transcript
Q2 FY2021 Aug 12, 2021 Read transcript
Shareholder/Analyst Calls Jun 9, 2021 Read transcript
Q1 FY2021 May 11, 2021 Read transcript
Q4 FY2020 Mar 25, 2021 Read transcript
Q3 FY2020 Nov 12, 2020 Read transcript
Q2 FY2020 Sep 14, 2020 Read transcript
Shareholder/Analyst Calls Sep 3, 2020 Read transcript
Q1 FY2020 May 14, 2020 Read transcript
Q4 FY2019 Mar 24, 2020 Read transcript